食品飲料板塊走強 佳禾食品等多股漲停
格隆匯5月14日丨食品飲料板塊走強,承德露露、祖名股份、西麥食品、佳禾食品、愛普股份等多隻個股漲停,熊貓乳品、雙塔食品、李子園、等個股紛紛大漲。消息上,辣條品牌衞龍已於5月12日向港交所提交上市申請書。有媒體稱,衞龍此輪融資投後估值高達700億元。市場人士認為,休閒食品市場份額分散,未來整合空間巨大,作為食品領域隱形巨頭,上市之後為想象空間較大。此外,燕麥奶品牌Oatly向美國證券交易委員會(SEC)更新了F-1招股説明書,計劃下週四在納斯達克掛牌上市,預期估值達100億美元甚至更高。作為植物奶第一股,市場對Oatly樂觀的估值可能部分來自於植物肉第一股Beyond meat的上市表現。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.